HK1067866A1 - Use of lh in controlled ovarian hyperstimulation - Google Patents

Use of lh in controlled ovarian hyperstimulation

Info

Publication number
HK1067866A1
HK1067866A1 HK05101453A HK05101453A HK1067866A1 HK 1067866 A1 HK1067866 A1 HK 1067866A1 HK 05101453 A HK05101453 A HK 05101453A HK 05101453 A HK05101453 A HK 05101453A HK 1067866 A1 HK1067866 A1 HK 1067866A1
Authority
HK
Hong Kong
Prior art keywords
ovarian hyperstimulation
controlled ovarian
controlled
hyperstimulation
ovarian
Prior art date
Application number
HK05101453A
Other languages
English (en)
Inventor
Stephen Hillier
Colin Michael Howles
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1067866(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of HK1067866A1 publication Critical patent/HK1067866A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK05101453A 2001-09-12 2005-02-22 Use of lh in controlled ovarian hyperstimulation HK1067866A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307755 2001-09-12
PCT/GB2002/004147 WO2003022301A2 (en) 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation

Publications (1)

Publication Number Publication Date
HK1067866A1 true HK1067866A1 (en) 2005-04-22

Family

ID=8182260

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05101453A HK1067866A1 (en) 2001-09-12 2005-02-22 Use of lh in controlled ovarian hyperstimulation

Country Status (28)

Country Link
US (1) US7341989B2 (de)
EP (1) EP1434600B1 (de)
JP (1) JP2005504072A (de)
KR (1) KR20040032953A (de)
CN (1) CN1302806C (de)
AR (1) AR036591A1 (de)
AT (1) ATE427755T1 (de)
AU (1) AU2002331939B2 (de)
BR (1) BR0212502A (de)
CA (1) CA2457067A1 (de)
CY (1) CY1110487T1 (de)
DE (1) DE60231892D1 (de)
DK (1) DK1434600T3 (de)
EA (1) EA009210B1 (de)
ES (1) ES2322136T3 (de)
HK (1) HK1067866A1 (de)
HR (1) HRP20040070A2 (de)
IL (1) IL160781A0 (de)
ME (1) MEP38808A (de)
MX (1) MXPA04002125A (de)
NO (1) NO327154B1 (de)
PL (1) PL205472B1 (de)
PT (1) PT1434600E (de)
RS (1) RS51505B (de)
SI (1) SI1434600T1 (de)
UA (1) UA78970C2 (de)
WO (1) WO2003022301A2 (de)
ZA (1) ZA200401008B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04012246A (es) * 2002-06-07 2005-04-08 Ares Trading Sa Metodo para la hiperestimulacion ovarica controlada y equipo farmaceutico para usarlo en dicho metodo.
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
RU2629871C1 (ru) * 2016-03-22 2017-09-04 Сергей Михайлович Юдин Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
WO2000067778A1 (en) * 1999-05-07 2000-11-16 Applied Research Systems Ars Holding N.V. Gonadotrophins

Also Published As

Publication number Publication date
RS51505B (sr) 2011-06-30
IL160781A0 (en) 2004-08-31
SI1434600T1 (sl) 2009-06-30
PT1434600E (pt) 2009-04-28
MXPA04002125A (es) 2004-07-08
MEP38808A (en) 2011-02-10
EP1434600B1 (de) 2009-04-08
US7341989B2 (en) 2008-03-11
DK1434600T3 (da) 2009-05-25
JP2005504072A (ja) 2005-02-10
UA78970C2 (uk) 2007-05-10
ES2322136T3 (es) 2009-06-17
CN1553809A (zh) 2004-12-08
CY1110487T1 (el) 2015-04-29
ZA200401008B (en) 2005-08-31
AU2002331939B2 (en) 2007-10-25
NO327154B1 (no) 2009-05-04
PL205472B1 (pl) 2010-04-30
CA2457067A1 (en) 2003-03-20
NO20040990L (no) 2004-03-08
WO2003022301A2 (en) 2003-03-20
KR20040032953A (ko) 2004-04-17
DE60231892D1 (de) 2009-05-20
ATE427755T1 (de) 2009-04-15
EA009210B1 (ru) 2007-12-28
AR036591A1 (es) 2004-09-22
BR0212502A (pt) 2004-08-24
HRP20040070A2 (en) 2004-10-31
EP1434600A2 (de) 2004-07-07
US20050049199A1 (en) 2005-03-03
PL367343A1 (en) 2005-02-21
YU21204A (sh) 2006-08-17
CN1302806C (zh) 2007-03-07
WO2003022301A3 (en) 2003-04-17
EA200400428A1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
HK1067867A1 (en) Use of hcg in controlled ovarian hyperstimulation
HK1067866A1 (en) Use of lh in controlled ovarian hyperstimulation
PL370480A1 (en) Aminopyrimidines and pyridines
HRP20031000A2 (en) Benzoylsulfonamides and sulfonylbenzamidines as antitumour agents
PL369855A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
HK1062457A1 (en) Modified and stabilized gdf propeptides and uses thereof
IL154553A0 (en) Urocortin-iii and uses thereof
GB0124730D0 (en) Improvements in or relating to devices
GB0116965D0 (en) Cosmetic devices
IL159963A0 (en) Novel benzo-fused heterocycles as endothelin antagonisits
SI1425033T1 (sl) Uporaba hcg in lh pri kontrolirani ovarijski hiperstimulaciji
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
GB2387737B (en) Improvements in or relating to telephone communications control devices
IL165522A0 (en) Controlled ovarian hyperstimulation
EP1353581A4 (de) Rucksack
GB0125287D0 (en) Controlling garment size
GB0125859D0 (en) Hand/wrist saving device
EP1367123A4 (de) Neurotonin und dessen verwendung
GB0219108D0 (en) Controlling electronic devices
GB0122316D0 (en) Threaded article
TW493609U (en) Moving and carrying device
GB2407736B (en) Improvements in or relating to telephone communications control devices
TW483458U (en) Anti-leaking block structure
CA93687S (en) Rucksack
GB2381908A8 (en) Integrated vertical-horizontal multi-portal

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160912